Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $54.7M; returns 1 day -0.2%, 1 week -4.0%, 1 year -50.7%.

Pliant Therapeutics Inc. (PLRX) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for fibrotic diseases, solid tumors, and muscular dystrophies.

Groups PLRX belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Clinical Stage
• Fibrosis
• Biopharmaceutical
• Oncology
• Drug Discovery
• R&D

PLRX financial model: income statement, cash flow and balance sheet